The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for J Xi


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors.EBI
Hangzhou Xixi Hospital
Design, synthesis and biological evaluation of novel non-covalent piperidine-containing peptidyl proteasome inhibitors.EBI
Hangzhou Xixi Hospital
Novel aromatase inhibitors by structure-guided design.EBI
State University of New York Upstate Medical University
Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates.EBI
Chengdu University of Traditional Chinese Medicine
Discovery of a Potent and Selective CCR8 Small Molecular Antagonist IPG7236 for the Treatment of Cancer.EBI
TBA
Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis.EBI
TBA
Optimization of piperidine constructed peptidyl derivatives as proteasome inhibitors.EBI
Hangzhou Xixi Hospital
Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.EBI
Hangzhou Xixi Hospital
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors.EBI
Hangzhou Xixi Hospital
BRD4 inhibitor as well as a preparative method and use thereofBDB
Hinova Pharmaceuticals
Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disordersBDB
Vitae Pharmaceuticals